Role of robot-assisted retroperitoneal lymph node dissection in malignant mesothelioma of the tunica vaginalis: case series and review of the literature

Kassem S. Faraj, Haidar M. Abdul-Muhsin, Anojan K. Navaratnam, Kyle M. Rose, Jeffrey Stagg, Thai H Ho, Alan H Bryce, Scott M. Cheney, Mark D. Tyson, Erik P Castle

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: The management of malignant mesothelioma of the tunica vaginalis (MMTVT) is not clearly defined. Retroperitoneal lymph node dissection has been reported as a potential management option. Herein we present our experience with robot-assisted retroperitoneal lymph node dissection (RARPLND) in our series of patients with MMTVT. MATERIALS AND METHODS: The Mayo Clinic cancer registry was queried from 1972-present for all patients who had a diagnosis of MMTVT. Six patients were identified, five of whom were treated with RPLND, where four underwent RARPLND. RESULTS: In five patients who underwent RPLND, the median age was 50 years (IQR 34-51). Four patients originally presented with right sided symptomatic hydroceles, while one presented with right sided chronic epididymitis. Orchiectomy (one simple, two inguinal radical) was performed in three patients prior to presentation. Preoperative cross-sectional imaging, including PET-CT scan in three patients, was negative for lymphadenopathy or metastasis. RARPLND was performed in 4/5 (80%) cases and concomitant hemiscrotectomy in 4/5 (80%) cases. Full bilateral template was performed in three patients and right modified template was performed in the remaining two. Median lymph node yield was 29 (IQR 22-32) and median blood loss was 275 cc (IQR 200-300). Positive retroperitoneal lymph nodes were found in 3/5 (60%) cases. All patients who underwent RARPLND were discharged home on postoperative day one. Mean follow up was 27 months (range 3-47). No patients recurred. CONCLUSIONS: Regardless of the approach, RPLND may provide a diagnostic benefit in patients who present with MMTVT, with the robotic approach affording a potentially expedited recovery.

Original languageEnglish (US)
Pages (from-to)9752-9757
Number of pages6
JournalThe Canadian journal of urology
Volume26
Issue number3
StatePublished - Jun 1 2019

Fingerprint

Lymph Node Excision
Lymph Nodes
Malignant Mesothelioma
Epididymitis
Orchiectomy
Groin
Robotics
Patient Rights
Registries
Neoplasm Metastasis

ASJC Scopus subject areas

  • Urology

Cite this

Role of robot-assisted retroperitoneal lymph node dissection in malignant mesothelioma of the tunica vaginalis : case series and review of the literature. / Faraj, Kassem S.; Abdul-Muhsin, Haidar M.; Navaratnam, Anojan K.; Rose, Kyle M.; Stagg, Jeffrey; Ho, Thai H; Bryce, Alan H; Cheney, Scott M.; Tyson, Mark D.; Castle, Erik P.

In: The Canadian journal of urology, Vol. 26, No. 3, 01.06.2019, p. 9752-9757.

Research output: Contribution to journalArticle

Faraj, Kassem S. ; Abdul-Muhsin, Haidar M. ; Navaratnam, Anojan K. ; Rose, Kyle M. ; Stagg, Jeffrey ; Ho, Thai H ; Bryce, Alan H ; Cheney, Scott M. ; Tyson, Mark D. ; Castle, Erik P. / Role of robot-assisted retroperitoneal lymph node dissection in malignant mesothelioma of the tunica vaginalis : case series and review of the literature. In: The Canadian journal of urology. 2019 ; Vol. 26, No. 3. pp. 9752-9757.
@article{949ace4ee9f24b3fabe8a2a857af0f68,
title = "Role of robot-assisted retroperitoneal lymph node dissection in malignant mesothelioma of the tunica vaginalis: case series and review of the literature",
abstract = "INTRODUCTION: The management of malignant mesothelioma of the tunica vaginalis (MMTVT) is not clearly defined. Retroperitoneal lymph node dissection has been reported as a potential management option. Herein we present our experience with robot-assisted retroperitoneal lymph node dissection (RARPLND) in our series of patients with MMTVT. MATERIALS AND METHODS: The Mayo Clinic cancer registry was queried from 1972-present for all patients who had a diagnosis of MMTVT. Six patients were identified, five of whom were treated with RPLND, where four underwent RARPLND. RESULTS: In five patients who underwent RPLND, the median age was 50 years (IQR 34-51). Four patients originally presented with right sided symptomatic hydroceles, while one presented with right sided chronic epididymitis. Orchiectomy (one simple, two inguinal radical) was performed in three patients prior to presentation. Preoperative cross-sectional imaging, including PET-CT scan in three patients, was negative for lymphadenopathy or metastasis. RARPLND was performed in 4/5 (80{\%}) cases and concomitant hemiscrotectomy in 4/5 (80{\%}) cases. Full bilateral template was performed in three patients and right modified template was performed in the remaining two. Median lymph node yield was 29 (IQR 22-32) and median blood loss was 275 cc (IQR 200-300). Positive retroperitoneal lymph nodes were found in 3/5 (60{\%}) cases. All patients who underwent RARPLND were discharged home on postoperative day one. Mean follow up was 27 months (range 3-47). No patients recurred. CONCLUSIONS: Regardless of the approach, RPLND may provide a diagnostic benefit in patients who present with MMTVT, with the robotic approach affording a potentially expedited recovery.",
author = "Faraj, {Kassem S.} and Abdul-Muhsin, {Haidar M.} and Navaratnam, {Anojan K.} and Rose, {Kyle M.} and Jeffrey Stagg and Ho, {Thai H} and Bryce, {Alan H} and Cheney, {Scott M.} and Tyson, {Mark D.} and Castle, {Erik P}",
year = "2019",
month = "6",
day = "1",
language = "English (US)",
volume = "26",
pages = "9752--9757",
journal = "Canadian Journal of Urology",
issn = "1195-9479",
publisher = "Canadian Journal of Urology",
number = "3",

}

TY - JOUR

T1 - Role of robot-assisted retroperitoneal lymph node dissection in malignant mesothelioma of the tunica vaginalis

T2 - case series and review of the literature

AU - Faraj, Kassem S.

AU - Abdul-Muhsin, Haidar M.

AU - Navaratnam, Anojan K.

AU - Rose, Kyle M.

AU - Stagg, Jeffrey

AU - Ho, Thai H

AU - Bryce, Alan H

AU - Cheney, Scott M.

AU - Tyson, Mark D.

AU - Castle, Erik P

PY - 2019/6/1

Y1 - 2019/6/1

N2 - INTRODUCTION: The management of malignant mesothelioma of the tunica vaginalis (MMTVT) is not clearly defined. Retroperitoneal lymph node dissection has been reported as a potential management option. Herein we present our experience with robot-assisted retroperitoneal lymph node dissection (RARPLND) in our series of patients with MMTVT. MATERIALS AND METHODS: The Mayo Clinic cancer registry was queried from 1972-present for all patients who had a diagnosis of MMTVT. Six patients were identified, five of whom were treated with RPLND, where four underwent RARPLND. RESULTS: In five patients who underwent RPLND, the median age was 50 years (IQR 34-51). Four patients originally presented with right sided symptomatic hydroceles, while one presented with right sided chronic epididymitis. Orchiectomy (one simple, two inguinal radical) was performed in three patients prior to presentation. Preoperative cross-sectional imaging, including PET-CT scan in three patients, was negative for lymphadenopathy or metastasis. RARPLND was performed in 4/5 (80%) cases and concomitant hemiscrotectomy in 4/5 (80%) cases. Full bilateral template was performed in three patients and right modified template was performed in the remaining two. Median lymph node yield was 29 (IQR 22-32) and median blood loss was 275 cc (IQR 200-300). Positive retroperitoneal lymph nodes were found in 3/5 (60%) cases. All patients who underwent RARPLND were discharged home on postoperative day one. Mean follow up was 27 months (range 3-47). No patients recurred. CONCLUSIONS: Regardless of the approach, RPLND may provide a diagnostic benefit in patients who present with MMTVT, with the robotic approach affording a potentially expedited recovery.

AB - INTRODUCTION: The management of malignant mesothelioma of the tunica vaginalis (MMTVT) is not clearly defined. Retroperitoneal lymph node dissection has been reported as a potential management option. Herein we present our experience with robot-assisted retroperitoneal lymph node dissection (RARPLND) in our series of patients with MMTVT. MATERIALS AND METHODS: The Mayo Clinic cancer registry was queried from 1972-present for all patients who had a diagnosis of MMTVT. Six patients were identified, five of whom were treated with RPLND, where four underwent RARPLND. RESULTS: In five patients who underwent RPLND, the median age was 50 years (IQR 34-51). Four patients originally presented with right sided symptomatic hydroceles, while one presented with right sided chronic epididymitis. Orchiectomy (one simple, two inguinal radical) was performed in three patients prior to presentation. Preoperative cross-sectional imaging, including PET-CT scan in three patients, was negative for lymphadenopathy or metastasis. RARPLND was performed in 4/5 (80%) cases and concomitant hemiscrotectomy in 4/5 (80%) cases. Full bilateral template was performed in three patients and right modified template was performed in the remaining two. Median lymph node yield was 29 (IQR 22-32) and median blood loss was 275 cc (IQR 200-300). Positive retroperitoneal lymph nodes were found in 3/5 (60%) cases. All patients who underwent RARPLND were discharged home on postoperative day one. Mean follow up was 27 months (range 3-47). No patients recurred. CONCLUSIONS: Regardless of the approach, RPLND may provide a diagnostic benefit in patients who present with MMTVT, with the robotic approach affording a potentially expedited recovery.

UR - http://www.scopus.com/inward/record.url?scp=85068467433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068467433&partnerID=8YFLogxK

M3 - Article

C2 - 31180304

AN - SCOPUS:85068467433

VL - 26

SP - 9752

EP - 9757

JO - Canadian Journal of Urology

JF - Canadian Journal of Urology

SN - 1195-9479

IS - 3

ER -